Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus

Susceptibility to behaviorally similar audiogenic seizures (AGS) occurs genetically and is inducible during ethanol withdrawal (ETX). Comparisons between AGS mechanisms of genetically epilepsy-prone rats (GEPR-9s) and ethanol-withdrawn rats (ETX-Rs) are yielding information about general pathophysio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2000-05, Vol.163 (1), p.264-270
Hauptverfasser: Feng, Hua-Jun, Faingold, Carl L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 270
container_issue 1
container_start_page 264
container_title Experimental neurology
container_volume 163
creator Feng, Hua-Jun
Faingold, Carl L.
description Susceptibility to behaviorally similar audiogenic seizures (AGS) occurs genetically and is inducible during ethanol withdrawal (ETX). Comparisons between AGS mechanisms of genetically epilepsy-prone rats (GEPR-9s) and ethanol-withdrawn rats (ETX-Rs) are yielding information about general pathophysiological mechanisms of epileptogenesis. The inferior colliculus (IC) is the AGS initiation site. Excitatory amino acid (EAA) abnormalities in the IC are implicated in AGS, and histamine and adenosine receptor activation each reduce EAA release and inhibit several seizure types. Previous studies indicate that focal infusion of an adenosine receptor agonist into the IC blocked AGS in GEPR-9s, but the effects of adenosine receptor activation in the IC on AGS in ETX-Rs are unknown. The effects of histamine receptor activation on either form of AGS are also unexamined. The present study evaluated effects of histamine or a nonselective adenosine A1 agonist, 2-chloroadenosine, on AGS by focal microinjection into the IC. Ethanol dependence and AGS susceptibility were induced in normal rats by intragastric ethanol. Histamine (40 or 60 nmol/side) significantly reduced AGS in GEPR-9s, but histamine in doses up to 120 nmol/side did not affect AGS in ETX-Rs. 2-Chloroadenosine (5 or 10 nmol/side) did not affect AGS in ETX-Rs, despite the effectiveness of lower doses of this agent in GEPR-9s reported previously. Thus, histamine and adenosine receptors in the IC modulate AGS of GEPR-9s, but do not modulate ETX-induced AGS. The reasons for this difference may involve the chronicity of AGS susceptibility in GEPR-9s, which may lead to more extensive neuromodulation as compensatory mechanisms to limit the seizures compared to the acute AGS of ETX-Rs.
doi_str_mv 10.1006/exnr.2000.7382
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_exnr_2000_7382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488600973825</els_id><sourcerecordid>S0014488600973825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-946fe027cc4df07fedd988573942de9e3389341e4229feecee9cd1efa0960e803</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMouq5ePUoOXlsnbbZNjsuirqAIfpxLNplopJssSSvqr7dlF_TiaRh43vl4CDljkDOA6hI_fcwLAMjrUhR7ZMJAQlbwEvbJBIDxjAtRHZHjlN4HSvKiPiRHDGox41U1Ieo-mL5VnQueBkvnvXHhFb3T9Anddx8x0dUXXbrUqbXzSJU3dG7QhzR2j6hx04WYqPO0e0N66y1GFyJdhLZ1um_7dEIOrGoTnu7qlLxcXz0vltndw83tYn6XaV7xLpO8sghFrTU3FmqLxkghZnU5nGxQYlkKWXKGvCikxWEvSm0YWgWyAhRQTkm-natjSCmibTbRrVX8ahg0o6tmdNWMrprR1RA43wY2_WqN5g--lTMAFztAJa1aG5XXLv1ynJUVzAZMbDEcvvtwGJukHXqNxkXUXWOC---EHw8ihsk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Feng, Hua-Jun ; Faingold, Carl L.</creator><creatorcontrib>Feng, Hua-Jun ; Faingold, Carl L.</creatorcontrib><description>Susceptibility to behaviorally similar audiogenic seizures (AGS) occurs genetically and is inducible during ethanol withdrawal (ETX). Comparisons between AGS mechanisms of genetically epilepsy-prone rats (GEPR-9s) and ethanol-withdrawn rats (ETX-Rs) are yielding information about general pathophysiological mechanisms of epileptogenesis. The inferior colliculus (IC) is the AGS initiation site. Excitatory amino acid (EAA) abnormalities in the IC are implicated in AGS, and histamine and adenosine receptor activation each reduce EAA release and inhibit several seizure types. Previous studies indicate that focal infusion of an adenosine receptor agonist into the IC blocked AGS in GEPR-9s, but the effects of adenosine receptor activation in the IC on AGS in ETX-Rs are unknown. The effects of histamine receptor activation on either form of AGS are also unexamined. The present study evaluated effects of histamine or a nonselective adenosine A1 agonist, 2-chloroadenosine, on AGS by focal microinjection into the IC. Ethanol dependence and AGS susceptibility were induced in normal rats by intragastric ethanol. Histamine (40 or 60 nmol/side) significantly reduced AGS in GEPR-9s, but histamine in doses up to 120 nmol/side did not affect AGS in ETX-Rs. 2-Chloroadenosine (5 or 10 nmol/side) did not affect AGS in ETX-Rs, despite the effectiveness of lower doses of this agent in GEPR-9s reported previously. Thus, histamine and adenosine receptors in the IC modulate AGS of GEPR-9s, but do not modulate ETX-induced AGS. The reasons for this difference may involve the chronicity of AGS susceptibility in GEPR-9s, which may lead to more extensive neuromodulation as compensatory mechanisms to limit the seizures compared to the acute AGS of ETX-Rs.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1006/exnr.2000.7382</identifier><identifier>PMID: 10785466</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>2-chloroadenosine ; 2-Chloroadenosine - administration &amp; dosage ; 2-Chloroadenosine - pharmacology ; Acoustic Stimulation ; Alcohol Withdrawal Seizures - drug therapy ; Alcohol Withdrawal Seizures - metabolism ; Animals ; audiogenic seizures ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Epilepsy, Reflex - drug therapy ; Epilepsy, Reflex - metabolism ; ethanol withdrawal ; genetically epilepsy-prone rats ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; histamine ; Histamine - administration &amp; dosage ; Histamine - pharmacology ; Inferior Colliculi - drug effects ; Inferior Colliculi - metabolism ; Inferior Colliculi - physiopathology ; inferior colliculus ; Medical sciences ; Microinjections ; Nervous system (semeiology, syndromes) ; Neurology ; neuromodulators ; Purinergic P1 Receptor Agonists ; Rats ; Rats, Inbred Strains ; Rats, Sprague-Dawley</subject><ispartof>Experimental neurology, 2000-05, Vol.163 (1), p.264-270</ispartof><rights>2000 Academic Press</rights><rights>2000 INIST-CNRS</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-946fe027cc4df07fedd988573942de9e3389341e4229feecee9cd1efa0960e803</citedby><cites>FETCH-LOGICAL-c464t-946fe027cc4df07fedd988573942de9e3389341e4229feecee9cd1efa0960e803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/exnr.2000.7382$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>310,311,315,781,785,790,791,3551,23935,23936,25145,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1413605$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10785466$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Hua-Jun</creatorcontrib><creatorcontrib>Faingold, Carl L.</creatorcontrib><title>Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Susceptibility to behaviorally similar audiogenic seizures (AGS) occurs genetically and is inducible during ethanol withdrawal (ETX). Comparisons between AGS mechanisms of genetically epilepsy-prone rats (GEPR-9s) and ethanol-withdrawn rats (ETX-Rs) are yielding information about general pathophysiological mechanisms of epileptogenesis. The inferior colliculus (IC) is the AGS initiation site. Excitatory amino acid (EAA) abnormalities in the IC are implicated in AGS, and histamine and adenosine receptor activation each reduce EAA release and inhibit several seizure types. Previous studies indicate that focal infusion of an adenosine receptor agonist into the IC blocked AGS in GEPR-9s, but the effects of adenosine receptor activation in the IC on AGS in ETX-Rs are unknown. The effects of histamine receptor activation on either form of AGS are also unexamined. The present study evaluated effects of histamine or a nonselective adenosine A1 agonist, 2-chloroadenosine, on AGS by focal microinjection into the IC. Ethanol dependence and AGS susceptibility were induced in normal rats by intragastric ethanol. Histamine (40 or 60 nmol/side) significantly reduced AGS in GEPR-9s, but histamine in doses up to 120 nmol/side did not affect AGS in ETX-Rs. 2-Chloroadenosine (5 or 10 nmol/side) did not affect AGS in ETX-Rs, despite the effectiveness of lower doses of this agent in GEPR-9s reported previously. Thus, histamine and adenosine receptors in the IC modulate AGS of GEPR-9s, but do not modulate ETX-induced AGS. The reasons for this difference may involve the chronicity of AGS susceptibility in GEPR-9s, which may lead to more extensive neuromodulation as compensatory mechanisms to limit the seizures compared to the acute AGS of ETX-Rs.</description><subject>2-chloroadenosine</subject><subject>2-Chloroadenosine - administration &amp; dosage</subject><subject>2-Chloroadenosine - pharmacology</subject><subject>Acoustic Stimulation</subject><subject>Alcohol Withdrawal Seizures - drug therapy</subject><subject>Alcohol Withdrawal Seizures - metabolism</subject><subject>Animals</subject><subject>audiogenic seizures</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Epilepsy, Reflex - drug therapy</subject><subject>Epilepsy, Reflex - metabolism</subject><subject>ethanol withdrawal</subject><subject>genetically epilepsy-prone rats</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>histamine</subject><subject>Histamine - administration &amp; dosage</subject><subject>Histamine - pharmacology</subject><subject>Inferior Colliculi - drug effects</subject><subject>Inferior Colliculi - metabolism</subject><subject>Inferior Colliculi - physiopathology</subject><subject>inferior colliculus</subject><subject>Medical sciences</subject><subject>Microinjections</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>neuromodulators</subject><subject>Purinergic P1 Receptor Agonists</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Rats, Sprague-Dawley</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LxDAQhoMouq5ePUoOXlsnbbZNjsuirqAIfpxLNplopJssSSvqr7dlF_TiaRh43vl4CDljkDOA6hI_fcwLAMjrUhR7ZMJAQlbwEvbJBIDxjAtRHZHjlN4HSvKiPiRHDGox41U1Ieo-mL5VnQueBkvnvXHhFb3T9Anddx8x0dUXXbrUqbXzSJU3dG7QhzR2j6hx04WYqPO0e0N66y1GFyJdhLZ1um_7dEIOrGoTnu7qlLxcXz0vltndw83tYn6XaV7xLpO8sghFrTU3FmqLxkghZnU5nGxQYlkKWXKGvCikxWEvSm0YWgWyAhRQTkm-natjSCmibTbRrVX8ahg0o6tmdNWMrprR1RA43wY2_WqN5g--lTMAFztAJa1aG5XXLv1ynJUVzAZMbDEcvvtwGJukHXqNxkXUXWOC---EHw8ihsk</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Feng, Hua-Jun</creator><creator>Faingold, Carl L.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20000501</creationdate><title>Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus</title><author>Feng, Hua-Jun ; Faingold, Carl L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-946fe027cc4df07fedd988573942de9e3389341e4229feecee9cd1efa0960e803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>2-chloroadenosine</topic><topic>2-Chloroadenosine - administration &amp; dosage</topic><topic>2-Chloroadenosine - pharmacology</topic><topic>Acoustic Stimulation</topic><topic>Alcohol Withdrawal Seizures - drug therapy</topic><topic>Alcohol Withdrawal Seizures - metabolism</topic><topic>Animals</topic><topic>audiogenic seizures</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Epilepsy, Reflex - drug therapy</topic><topic>Epilepsy, Reflex - metabolism</topic><topic>ethanol withdrawal</topic><topic>genetically epilepsy-prone rats</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>histamine</topic><topic>Histamine - administration &amp; dosage</topic><topic>Histamine - pharmacology</topic><topic>Inferior Colliculi - drug effects</topic><topic>Inferior Colliculi - metabolism</topic><topic>Inferior Colliculi - physiopathology</topic><topic>inferior colliculus</topic><topic>Medical sciences</topic><topic>Microinjections</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>neuromodulators</topic><topic>Purinergic P1 Receptor Agonists</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Hua-Jun</creatorcontrib><creatorcontrib>Faingold, Carl L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Hua-Jun</au><au>Faingold, Carl L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>163</volume><issue>1</issue><spage>264</spage><epage>270</epage><pages>264-270</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>Susceptibility to behaviorally similar audiogenic seizures (AGS) occurs genetically and is inducible during ethanol withdrawal (ETX). Comparisons between AGS mechanisms of genetically epilepsy-prone rats (GEPR-9s) and ethanol-withdrawn rats (ETX-Rs) are yielding information about general pathophysiological mechanisms of epileptogenesis. The inferior colliculus (IC) is the AGS initiation site. Excitatory amino acid (EAA) abnormalities in the IC are implicated in AGS, and histamine and adenosine receptor activation each reduce EAA release and inhibit several seizure types. Previous studies indicate that focal infusion of an adenosine receptor agonist into the IC blocked AGS in GEPR-9s, but the effects of adenosine receptor activation in the IC on AGS in ETX-Rs are unknown. The effects of histamine receptor activation on either form of AGS are also unexamined. The present study evaluated effects of histamine or a nonselective adenosine A1 agonist, 2-chloroadenosine, on AGS by focal microinjection into the IC. Ethanol dependence and AGS susceptibility were induced in normal rats by intragastric ethanol. Histamine (40 or 60 nmol/side) significantly reduced AGS in GEPR-9s, but histamine in doses up to 120 nmol/side did not affect AGS in ETX-Rs. 2-Chloroadenosine (5 or 10 nmol/side) did not affect AGS in ETX-Rs, despite the effectiveness of lower doses of this agent in GEPR-9s reported previously. Thus, histamine and adenosine receptors in the IC modulate AGS of GEPR-9s, but do not modulate ETX-induced AGS. The reasons for this difference may involve the chronicity of AGS susceptibility in GEPR-9s, which may lead to more extensive neuromodulation as compensatory mechanisms to limit the seizures compared to the acute AGS of ETX-Rs.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>10785466</pmid><doi>10.1006/exnr.2000.7382</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2000-05, Vol.163 (1), p.264-270
issn 0014-4886
1090-2430
language eng
recordid cdi_crossref_primary_10_1006_exnr_2000_7382
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects 2-chloroadenosine
2-Chloroadenosine - administration & dosage
2-Chloroadenosine - pharmacology
Acoustic Stimulation
Alcohol Withdrawal Seizures - drug therapy
Alcohol Withdrawal Seizures - metabolism
Animals
audiogenic seizures
Biological and medical sciences
Dose-Response Relationship, Drug
Epilepsy, Reflex - drug therapy
Epilepsy, Reflex - metabolism
ethanol withdrawal
genetically epilepsy-prone rats
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
histamine
Histamine - administration & dosage
Histamine - pharmacology
Inferior Colliculi - drug effects
Inferior Colliculi - metabolism
Inferior Colliculi - physiopathology
inferior colliculus
Medical sciences
Microinjections
Nervous system (semeiology, syndromes)
Neurology
neuromodulators
Purinergic P1 Receptor Agonists
Rats
Rats, Inbred Strains
Rats, Sprague-Dawley
title Modulation of Audiogenic Seizures by Histamine and Adenosine Receptors in the Inferior Colliculus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T02%3A46%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20Audiogenic%20Seizures%20by%20Histamine%20and%20Adenosine%20Receptors%20in%20the%20Inferior%20Colliculus&rft.jtitle=Experimental%20neurology&rft.au=Feng,%20Hua-Jun&rft.date=2000-05-01&rft.volume=163&rft.issue=1&rft.spage=264&rft.epage=270&rft.pages=264-270&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1006/exnr.2000.7382&rft_dat=%3Celsevier_cross%3ES0014488600973825%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10785466&rft_els_id=S0014488600973825&rfr_iscdi=true